Glucagonoma laboratory tests: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
|||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Laboratory findings consistent with the diagnosis of glucagonoma include a serum [[glucagon]] concentration of 1000 pg/ml or greater. | Laboratory findings consistent with the diagnosis of glucagonoma include a serum [[glucagon]] concentration of 1000 pg/ml or greater. | ||
==Laboratory Findings== | ==Laboratory Findings== |
Revision as of 16:56, 20 November 2017
Glucagonoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Glucagonoma laboratory tests On the Web |
American Roentgen Ray Society Images of Glucagonoma laboratory tests |
Risk calculators and risk factors for Glucagonoma laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2], Mohammed Abdelwahed M.D[3]
Overview
Laboratory findings consistent with the diagnosis of glucagonoma include a serum glucagon concentration of 1000 pg/ml or greater.
Laboratory Findings
The laboratory findings associated with glucagonoma are:[1][2][3]
Serum glucagon
- Increased plasma glucagon levels >500 pg/mL (Normal glucagon level is less than 50 pg/mL).
- Concentrations above 1000 pg/mL are diagnostic of glucagonoma.
- Some conditions can increase glucagon level to a level less than 500 pg/mL such as fasting and hypoglycemia.
- Some symptomatic glucagonomas are associated with normal glucagon serum level. So, a serum glucagon concentration below 500 pg/mL does not exclude a glucagonoma.[3]
Other laboratory findings
- Blood tests may also reveal low concentrations of amino acids, zinc, and essential fatty acids.
- A complete blood count (CBC) to diagnose anemia.
References
- ↑ Invalid
<ref>
tag; no text was provided for refs namedpmid15313692
- ↑ Invalid
<ref>
tag; no text was provided for refs namedpmid8606627
- ↑ 3.0 3.1 Kindmark H, Sundin A, Granberg D, Dunder K, Skogseid B, Janson ET; et al. (2007). "Endocrine [[pancreatic tumors]] with [[glucagon]] hypersecretion: a retrospective study of 23 cases during 20 years". Med Oncol. 24 (3): 330–7. PMID 17873310. URL–wikilink conflict (help)